Entrada Therapeutics, Inc. (TRDA)
Entrada Therapeutics, Inc. (TRDA) has a 18-report earnings history dating back to Dec 09, 2021. Its average absolute post-earnings move is ±8.52%, and 72.2% of those reactions were positive. Its largest post-earnings gain was +11.26% (Aug 13, 2024) and its largest decline was -57.04% (May 07, 2026). The next earnings report is predicted for 2026-08-10 (approximate).
Earnings reactions
How TRDA moved on each past earnings report.
Earnings Impact
Total Earnings
18
Avg Abs. Movement
±8.52%
Positive %
72.2%
Negative %
27.8%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 07, 2026 | ☀ PRE | -57.04% | open_in_new |
| Feb 26, 2026 | ☀ PRE | +6.76% | open_in_new |
| Nov 06, 2025 | ☀ PRE | +0.14% | open_in_new |
| Aug 06, 2025 | ☀ PRE | +2.06% | open_in_new |
Earnings Count
18
Total earnings in dataset
Avg Abs. Movement
±8.52%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260612 | open_in_new SEC.gov |
| 4 | 20260612 | open_in_new SEC.gov |
| 4 | 20260612 | open_in_new SEC.gov |
| 4 | 20260612 | open_in_new SEC.gov |
| 4 | 20260612 | open_in_new SEC.gov |
| 4 | 20260612 | open_in_new SEC.gov |
| 8-K | 20260610 | open_in_new SEC.gov |
| 4 | 20260521 | open_in_new SEC.gov |
| 8-K | 20260519 | open_in_new SEC.gov |
| 10-Q | 20260507 | open_in_new SEC.gov |
Frequently asked about TRDA earnings
When does Entrada Therapeutics, Inc. report earnings next? expand_more
Entrada Therapeutics, Inc. (TRDA)'s next earnings date is approximate for 2026-08-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does TRDA stock move after earnings? expand_more
Over 18 reports, TRDA has moved an average of ±8.52% the session after earnings, closing higher 72.2% of the time.
What was TRDA's biggest post-earnings move? expand_more
TRDA's largest post-earnings gain on record was +11.26% on Aug 13, 2024, and its largest decline was -57.04% on May 07, 2026.
Where can I find Entrada Therapeutics, Inc.'s SEC filings? expand_more
All of Entrada Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right
Reporting around the same time
- ALICO, INC. (ALCO) earnings 2026-08-07
- ASCENT INDUSTRIES CO. (ACNT) earnings 2026-08-07
- Aclaris Therapeutics, Inc. (ACRS) earnings 2026-08-07
- ACV Auctions Inc. (ACVA) earnings 2026-08-07
- ADC Therapeutics SA (ADCT) earnings 2026-08-07
- ADMA BIOLOGICS, INC. (ADMA) earnings 2026-08-07
- Aeva Technologies, Inc. (AEVA) earnings 2026-08-07
- Agenus Inc. Common Stock (AGEN) earnings 2026-08-07